health

Medical student, 21, died a day after getting J&J vaccine


John Foley, 21 (pictured), a student at the University of Cincinnati in Ohio received the Johnson & Johnson coronavirus vaccine on Saturday and was discovered by his roommates on Sunday

John Foley, 21 (pictured), a student at the University of Cincinnati in Ohio received the Johnson & Johnson coronavirus vaccine on Saturday and was discovered by his roommates on Sunday

Officials are investigating the death of a University of Cincinnati student one day after he received Johnson & Johnson’s one-dose COVID-19 vaccine. 

John Foley, 21, a pre-med junior, passed away on Sunday. His body was discovered shortly afterwards by his college roommates, reported FOX 19.

The Ohio Department of Health and the Hamilton County Coroner’s Office are awaiting medical records and test results before determining the cause of death.

It comes as the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) announced on Tuesday they were recommending a pause of the shot after six women developed rare, but serious, blood clots out of 7.2 million vaccinations. 

The figure of six was later updated to include nine people, including two people during clinical trials and seven after the vaccine was approved for emergency use, including one person who died.

There is no currently no evidence to suggest that the one-shot vaccine was the cause of Foley’s death. 

Hamilton County Coroner Lakshmi Sammarco told reporters on Friday afternoon that a preliminary autopsy report indicated his cause of death might have been a heart or breathing issue, not a blood clot. 

‘By preliminary autopsy findings, we don’t see a direct connection between the two,’ Sammarco said, according to WLWT.

‘There’s some misinformation about clots or pulmonary embolism, and again on autopsy, we did not find any evidence of that. 

There is currently no evidence the vaccine caused Foley's death, but the fatality is under investigation by the Ohio Department of Health and the Hamilton County Coroner's Office. Pictured: Johnson & Johnson COVID-19 vaccine in Hartford, Connecticut, March 2021

There is currently no evidence the vaccine caused Foley’s death, but the fatality is under investigation by the Ohio Department of Health and the Hamilton County Coroner’s Office. Pictured: Johnson & Johnson COVID-19 vaccine in Hartford, Connecticut, March 2021

Foley received the shot on Saturday morning, when he began feeling ill. He never woke up and passed away in his sleep. 

According to his parents, Mary Beth and Michael, Foley was a National Honor Society member who made the Dean’s List every semester. 

‘Our beloved son John Francis Foley is gone, and our family mourns the loss of this wonderful and sweet joy of our lives,’ a statement from his parents, released by their attorney, reads in part.

‘While the facts remain unclear on how he died, we are rejoicing in how he lived: caring for others, lit with God’s grace, and generous to all.

‘We know the doctors involved are doing their best. We must be patient, and we ask everyone else to be patient, too. John was going to be a doctor, so this is what he would want.’  

News of his death comes after a 43-year-old father-of-seven was reportedly left partially paralyzed after receiving the shot.   

Brad Malagarie, of St. Martin, Mississippi, suffered a stroke caused by a blood clot in his left middle cerebral artery in his brain within four hours of being inoculated with the one-dose shot, his family claimed in a Facebook donation page set up to help pay for his recovery.   

All previous reports of blood clots occurred between six and 13 days after receiving the one-dose shot compared to Malgarie, who suffered the clot just a few hours later. 

After delaying a vote on Wednesday, the CDC’s advisory committee is set to meet again on April 23 to recommend whether or not lift the pause on J&J’s vaccine.

There is no evidence the vaccine caused Malagarie’s clot, but his family told WLOX they are convinced the shot is to blame.

The 43-year-old received the COVID-19 vaccine around midday on April 6 and returned to his office.

A Mississippi man, 43, has been left paralyzed on one side of his body and unable to talk after receiving the Johnson & Johnson COVID-19 vaccine, according to the man's family. Brad Malagarie pictured with his wife Cori

A Mississippi man, 43, has been left paralyzed on one side of his body and unable to talk after receiving the Johnson & Johnson COVID-19 vaccine, according to the man’s family. Brad Malagarie pictured with his wife Cori

The father-of-seven (pictured with his wife and children), of St. Martin, Mississippi, suffered a stroke caused by a blood clot in his left middle cerebral artery in his brain

The father-of-seven (pictured with his wife and children), of St. Martin, Mississippi, suffered a stroke caused by a blood clot in his left middle cerebral artery in his brain

A few hours later, his coworkers noticed he was slumped unresponsive at his desk and he was rushed to hospital, the outlet reported.  

Doctors diagnosed him with a stroke caused by the blood clot in his brain.

Celeste Foster O’Keefe, Malagarie’s aunt and boss, said her nephew suffered from high blood pressure but managed it with medication.

‘They called me and said he had that vaccine and something is wrong, we think it’s a stroke,’ she said.  

‘He’s a young, healthy 43-year-old, and I immediately thought it, and I said be sure to tell the doctors he took that J & J vaccine and that, to me, is what caused his stroke.’  

The CDC and the FDA recommended that rollout of the vaccines be paused after nine reports of rare, but serious, blood clots out of 7.2 million vaccinations

J&J’S VACCINE AND BLOOD CLOTS: WHAT YOU NEED TO KNOW

The CDC and the FDA recommended that rollout of the J&J vaccine be paused on Tuesday after multiple reports of rare, but serious, blood clots.

Nine people between the ages of 18 and 59 developed cerebral venous sinus thrombosis (CVST).

CVST is a rare type of blood clot that blocks the brain’s sinus channels of draining blood, which can cause hemorrhages.

One of the nine patients died and two are in critical condition. 

With more than seven million people who have gotten the vaccine, this means just 0.00012% developed CVST.

That is less that the five out of one million people – 0.0005% – who develop the condition in the general population.

The CDC and FDA say these events seem to occur one week to ‘not longer than three weeks’ after vaccination. 

Although there are theories that the J&J vaccine may cause a rare autoimmune reaction, there is currently no evidence to suggest the shot is linked to blood clots.

Additionally, even though eight out of the nine cases have been reported in women, there is not enough information to suggest any particular subgroup is more vulnerable.

The father of seven, who is being treated at Ochsner Medical Center in Louisiana, has now left the ICU and is in a critical but stable condition but is still unable to talk or move the right side of his body, she said.   

‘He can’t talk now and he can’t walk. He’s paralyzed on the right side. He knows who we are and he will just cry when he sees us,’ O’Keefe said.

It is not clear yet if he will regain speech and movement but doctors have told the family it could be a long road to recovery.   

The Mississippi State Department of Health said in a statement it was ‘saddened’ to learn of Malagarie’s condition and is investigating but said it was ‘difficult, if not impossible’ to know if it is linked to the vaccine at this stage. 

‘The Mississippi State Department of Health is saddened to hear about the recent illness of Mr. Malagarie and wishes him well,’ the health department told WLOX.

‘The Agency is certainly investigating the situation. It is difficult, if not impossible, to assign a cause and effect at this time. 

‘It is important to note that strokes are not associated with this vaccine – instead a rare clotting syndrome has been identified.’

The department pointed out that the confirmed cases so far have all been in women and that reactions occurred several days after getting the shot.  

‘Further, adverse reaction has been cited between six and 13 days after the vaccine was administered,’ they said.  

Mississippi paused all administration of the J&J vaccine this week on the advice of the CDC and FDA. 

It emerged Friday that J&J had reached out to other vaccine makers to join forces in investigating the risk of blood clots, according to a report from the Wall Street Journal.  

Sources told the outlet, the pharma giant wanted to create an industry group to both look into the concerns and jointly communicate with the public.

Mississippi Health Department said it is investigating but that it is 'difficult, if not impossible' to know if Malagarie's condition is linked to the vaccine at this stage. Malagarie with his family

Mississippi Health Department said it is investigating but that it is ‘difficult, if not impossible’ to know if Malagarie’s condition is linked to the vaccine at this stage. Malagarie with his family 

Malagarie and his family who believe the vaccine is tied to his condition. The CDC and FDA recommended a pause in the rollout of J&J's vaccine, after 6 women developed blood clots after receiving it, including one who died

Malagarie and his family who believe the vaccine is tied to his condition. The CDC and FDA recommended a pause in the rollout of J&J’s vaccine, after 6 women developed blood clots after receiving it, including one who died

Malagarie and his wife Cori. It is too early to tell whether or not the vaccine is causing blood clots but only 6 blood clot cases have been confirmed out of 7.1 million Americans who have received the shot

Malagarie and his wife Cori. It is too early to tell whether or not the vaccine is causing blood clots but only 6 blood clot cases have been confirmed out of 7.1 million Americans who have received the shot

Dr. Fauci says he believes the J&J vaccine rollout will be ‘back on track’ soon

Dr. Fauci has said he believes the J&J vaccine rollout will soon be ‘back on track’ and that health officials will ‘quickly’ reach a conclusion over its safety.

The nation’s leading infectious disease expert told Reuters Thursday: ‘I believe that ultimately it will get back on track.

‘I hope it does, but you know, from what I’ve seen, I believe that it will.’  

His comments came as the CDC committee extended its pause on the vaccine due to a lack of data on the risks.   

‘I hope they make the conclusion of this quickly and get back on track, I hope so, and I believe they will,’ Fauci said. 

Fauci said earlier this week the pause is a sign the CDC and FDA ‘take safety really very seriously’ but denied that it would fuel distrust in the vaccine.

Moderna and Pfizer – the makers of the two other vaccines available in the US – are said to have declined while AstraZeneca was happy to come on board.

AstraZeneca, which the US has not authorized but is administered in many other countries including the UK and Australia, has also seen rare reports of clots in people who have received its vaccine.

In its case, British and European regulators have stressed that the benefits of vaccination outweigh the risks. 

The CDC and FDA issued its shock advice to pause the J&J rollout Tuesday.

The same day, J&J also announced it was delaying the rollout of the vaccine in Europe, and pausing clinical trials while it investigates the possible link to blood clots.  

Of the 7.1 million people who have received the one-shot vaccine in the US and been protected from COVID-19, only six cases of blood clots have been confirmed. 

This equates to 0.00008 percent of those who received the shot.

Meanwhile, 0.27 percent of the US population suffer from Deep Vein Thrombosis – a more severe form of blood clot – every year.  

All of the cases so far involved women aged between 18 and 48 years old.   

It is not clear if the women had underlying conditions that may have caused them to be more likely to get blood clots. 

One of the woman died and another is in critical condition in the hospital in Nebraska. 

US VACCINE SPLIT 

Pfizer  99.4MILLION 

5.7million per week

Moderna – 85.4MILLION 

5million per week

J&J  – 7.2Million  

1million per week roughly 

The CDC is also now investigating the death of a 45-year-old woman in Virginia who also recently had the vaccine while another possible case was reported Wednesday in a 28-year-old woman. 

The CDC said Wednesday there was no proof the vaccine causes the extremely rare blood clots but said its rollout was halted to give officials time to talk to doctors about how to treat the condition.

Some experts and doctors have called the decision to suspend the shot an ‘overreaction’ that will stunt the US’s COVID-19 recovery, with some pointing out that COVID-19 is more likely to cause blood clots than the vaccine. 

‘You’re much more likely to clot from the real COVID-19 virus, which is about 1 in 20 people hospitalized or even 1 in 100 recovering at home. 

‘That’s far more likely,’ Dr. Purvi Parikh told CNBC.

The vaccine was seen as a beacon of hope in the nation’s fight against the virus because it is administered via one shot – compared to the two doses required for the Pfizer and Moderna vaccines.  

Health officials are urging people who have received the vaccine not to panic, and to contact a doctor if they develop severe headaches, abdominal or leg pains or shortness of breath within three weeks of receiving it.   

CDC DELAYS VOTE ON WHETHER TO LIFT PAUSE ON J&J VACCINE

By Mary Kekatos, Senior Health Reporter for DailyMail.com

A Centers for Disease Control and Prevention (CDC) committee on Wednesday delayed its vote on whether or not to recommend lifting the pause of the Johnson & Johnson coronavirus vaccine.

The meeting was convened after the CDC and the U.S. Food and Drug Administration (FDA) suggested clinicians stop using the shot after nine reports of rare, but serious, blood clots out of 7.2 million vaccinations.

Two reports occurred during clinical trials and seven occurred after the vaccine was approved for emergency use authorization in February.   

Eight cases were among women from ages 18 to 59. One woman died and two are currently in critical condition.

Members of the Advisory Committee on Immunization Practices (ACIP), which develops guidelines for vaccine administration as well as schedules, appeared to want more data before proceeding with a decision.

‘ACIP does not wish to vote or put any motions on the table to vote on change to the current recommendation,’ the committee wrote in a statement.

The group is going to reconvene again in seven to 10 days, during which members will have time to review a better risk assessment, meaning the pause of J&J’s jab will continue.  

J&J’s vaccine combines genetic material from the new virus with the genes of the adenovirus – which causes the common cold – to induce an immune response.

It is the same technology the company used to make an experimental Ebola vaccine for people in the Democratic Republic of Congo in late 2019.

The vaccine was hailed as a game changer in the fight against coronavirus because it is a single-dose and it dd not have to be stored at freezing temperatures unlike the Pfizer-BioNTech and the Moderna vaccines.

So it was a shock when a report found that six women who received the J&J COVID-19 vaccine had developed cerebral venous sinus thrombosis (CVST) blood clots.

CVST is a rare type of blood clot that blocks the brain’s sinus channels of draining blood, which can cause hemorrhages.

It occurs in about five per million people in the general population.  





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more